Literature DB >> 17443466

Trial design for mold-active agents: time to break the mold--aspergillosis in neutropenic adults.

E J Anaissie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17443466     DOI： 10.1086/514352

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  9 in total

1.  Assessing responses to treatment of opportunistic mycoses and salvage strategies.

Authors:  Baldeep Wirk; John R Wingard
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

Review 2.  Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.

Authors:  Brahm H Segal; Raoul Herbrecht; David A Stevens; Luis Ostrosky-Zeichner; Jack Sobel; Claudio Viscoli; Thomas J Walsh; Johan Maertens; Thomas F Patterson; John R Perfect; Bertrand Dupont; John R Wingard; Thierry Calandra; Carol A Kauffman; John R Graybill; Lindsey R Baden; Peter G Pappas; John E Bennett; Dimitrios P Kontoyiannis; Catherine Cordonnier; Maria Anna Viviani; Jacques Bille; Nikolaos G Almyroudis; L Joseph Wheat; Wolfgang Graninger; Eric J Bow; Steven M Holland; Bart-Jan Kullberg; William E Dismukes; Ben E De Pauw
Journal:  Clin Infect Dis       Date:  2008-09-01       Impact factor: 9.079

3.  Baseline platelet count and creatinine clearance rate predict the outcome of neutropenia-related invasive aspergillosis.

Authors:  Simone Aranha Nouér; Marcio Nucci; Naveen Sanath Kumar; Monica Grazziutti; Alejandro Restrepo; Elias Anaissie
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

4.  Earlier response assessment in invasive aspergillosis based on the kinetics of serum Aspergillus galactomannan: proposal for a new definition.

Authors:  Simone A Nouér; Marcio Nucci; Naveen Sanath Kumar; Monica Grazziutti; Bart Barlogie; Elias Anaissie
Journal:  Clin Infect Dis       Date:  2011-08-16       Impact factor: 9.079

5.  Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients.

Authors:  Anne Bergeron; Raphaël Porcher; Jean Menotti; Jean Louis Poirot; Karine Chagnon; Anne Vekhoff; Muriel Cornet; Françoise Isnard; Emmanuel Raffoux; Benoit Brethon; Claire Lacroix; Sophie Touratier; Jean Paul Latgé; Claire Bouges-Michel; Abdellatif Tazi; Francis Derouin; Patricia Ribaud; Annie Sulahian
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

6.  Early Diagnosis of Invasive Aspergillosis in Neutropenic Patients. Comparison between Serum Galactomannan and Polymerase Chain Reaction.

Authors:  Rodrigo Lopes da Silva; Patrícia Ribeiro; Natacha Abreu; Teresa Ferreira; Teresa Fernandes; Alexandra Monteiro; Fátima Costa; Joana Caldas; Madalena Silva; Luísa Carande; Gilda Ferreira; António Conduto; Ernesto Cruz; Maria Henrique Sousa; António Silva Rodrigues; Isabel Costa; Joana Veiga; Aida Botelho de Sousa
Journal:  Clin Med Insights Oncol       Date:  2010-07-27

7.  Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis.

Authors:  Dionysios Neofytos; Radha Railkar; Kathleen M Mullane; David N Fredricks; Bruno Granwehr; Kieren A Marr; Nikolaos G Almyroudis; Dimitrios P Kontoyiannis; Johan Maertens; Rebecca Fox; Cameron Douglas; Robert Iannone; Eunkyung Kauh; Norah Shire
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

8.  Serum galactomannan assay for diagnosis of probable invasive Aspergillosis in acute leukemia and hematopoietic stem cell transplantation.

Authors:  Indranil Ghosh; Vinod Raina; Lalit Kumar; Atul Sharma; Sameer Bakhshi; Sobuhi Iqbal
Journal:  Indian J Med Paediatr Oncol       Date:  2013-04

9.  Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study.

Authors:  Tafireyi Marukutira; Shirish Huprikar; Nkechi Azie; Shun-Ping Quan; Herwig-Ulf Meier-Kriesche; David L Horn
Journal:  HIV AIDS (Auckl)       Date:  2014-03-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.